Background Epidemic influenza causes serious mortality and morbidity in temperate countries each winter. Research suggests that schoolchildren are critical in the spread of influenza virus, while the elderly and the very young are most vulnerable to the disease. Under these conditions, it is unclear how best to focus prevention efforts in order to protect the population. Here we investigate the question of how to protect a population against a disease when one group is particularly effective at spreading disease and another group is more vulnerable to the effects of the disease. Methods and Findings We developed a simple mathematical model of an epidemic that includes assortative mixing between groups of hosts. We evaluate the impact of different vaccine allocation strategies across a wide range of parameter values. With this model we demonstrate that the optimal vaccination strategy is extremely sensitive to the assortativity of population mixing, as well as to the reproductive number of the disease in each group. Small differences in parameter values can change the best vaccination strategy from one focused on the most vulnerable individuals to one focused on the most transmissive individuals. Conclusions Given the limited amount of information about relevant parameters, we suggest that changes in vaccination strategy, while potentially promising, should be approached with caution. In particular, we find that, while switching vaccine to more active groups may protect vulnerable groups in many cases, switching too much vaccine, or switching vaccine under slightly different conditions, may lead to large increases in disease in the vulnerable group. This outcome is more likely when vaccine limitation is stringent, when mixing is highly structured, or when transmission levels are high.
References
[1]
Bridges CB, Harper SA, Fukuda K, Uyeki TM, Cox NJ, et al. (2003) Prevention and control of influenza: Recommendations of the advisory committee on immunization practices (ACIP). MMWR 52(RR08): 1–36.
[2]
Centers for Disease Control (2004) Updated interim influenza vaccination recommendations 2004–05 influenza season. MMWR 53: 1183–1184.
[3]
Gruber WC (1998) Children as a target for immunization. In: Nicholson KG, Webster RG, editors. Textbook of influenza. Oxford: Blackwell Science. pp. 435–444.
[4]
Reichert TA, Sugaya N, Fedson DS, Glezen WP, Simonsen L, et al. (2001) The Japanese experience with vaccinating schoolchildren against influenza. N Engl J Med 344: 889–896.
[5]
Glezen WP (2004) Control of influenza. Tex Heart Inst J 31: 39–41.
[6]
Brownstein JS, Kleinman KP, Mandl KD (2005) Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system. Am J Epidemiol 162: 686–693.
[7]
Longini IM Jr, Halloran ME (2005) Strategy for distribution of influenza vaccine to high-risk groups and children. Am J Epidemiol 161: 303–306.
[8]
Halloran ME, Longini IM Jr, Gaglani MJ, Schmotzer B, Fewlass C, et al. (2006) Community studies for vaccinating schoolchildren against influenza. Science 311: 615–616.
[9]
Patel R, Longini IM, Halloran ME (2005) Finding optimal vaccination strategies for pandemic influenza using genetic algorithms. J Theor Biol 234: 201–212.
[10]
Bansal S, Pourbohloul B, Meyers LA (2006) A comparative analysis of influenza vaccination programs. PLoS Med 3: e387.. doi:10.1371/journal.pmed.0030387.
[11]
Enserink M (2004) Influenza: Crisis underscores fragility of vaccine production system. Science 306: 385.
[12]
Busenberg S, Castillo-Chavez C (1991) A general solution of the problem of mixing of subpopulations and its application to risk-structured and age-structured models for the spread of AIDS. IMA J Math Appl Med Biol 8: 1–30.
[13]
Kermack WO, McKendrick AG (1927) A contribution to the mathematical theory of epidemics. J Proc Roy Soc Lon A 115: 700–721.
[14]
Dwyer G, Dushoff J, Elkinton JS, Levin SA (2000) Pathogen-driven outbreaks in forest defoliators revisited: Building models from experimental data. Am Nat 156: 105–120.
[15]
Ma JL, Earn DJD (2006) Generality of the final size formula for an epidemic of a newly invading infectious disease. Bull Math Biol 68: 679–702.
[16]
Dushoff J, Levin S (1995) The effects of population heterogeneity on disease invasion. Math Biosci 128: 25–40.
[17]
Gross PA, Hermogenes AW, Sacks HS, Lau J, Levandowski RA (1995) The efficacy of influenza vaccine in elderly persons: A meta-analysis and review of the literature. Ann Intern Med 123: 518–527.
[18]
Halloran ME, Longini IM, Gaglani MJ, Piedra PA, Chu H, et al. (2003) Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures. Am J Epidemiol 158: 305–311.
[19]
Jefferson T, Rivetti D, Rivetti A, Rudin M, Di Pietrantonj C, et al. (2005) Efficacy and effectiveness of influenza vaccines in elderly people: A systematic review. Lancet 366: 1165–1174.
[20]
Goodwin K, Viboud C, Simonsen L (2006) Antibody response to influenza vaccination in the elderly: A quantitative review. Vaccine 24: 1159–1169.
[21]
Jackson LA, Nelson JC, Benson P, Neuzil KM, Reid RJ, et al. (2006) Functional status is a confounder of the association of influenza vaccine and risk of all cause mortality in seniors. Int J Epidemiol 35: 345–352.
[22]
Jackson LA, Jackson ML, Nelson JC, Neuzil KM, Weiss NS (2006) Evidence of bias in estimates of influenza vaccine effectiveness in seniors. Int J Epidemiol 35: 337–344.
[23]
Monto AS, Davenport F, Napier JA, Francis T (1970) Modification of an outbreak of influenza in Tecumseh, Michigan by vaccination of schoolchildren. J Infect Dis 122: 16–25.
[24]
Piedra PA, Gaglani MJ, Riggs M, Herschler G, Fewlass C, et al. (2005) Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial. Pediatrics 116: e397–e407.
[25]
Simonsen L, Reichert TA, Viboud C, Blackwelder WC, Taylor RJ, et al. (2005) Impact of influenza vaccination on seasonal mortality in the US elderly population. Arch Intern Med 165: 265–272.
[26]
Dushoff J, Plotkin JB, Levin SA, Earn DJD (2004) Dynamical resonance can account for seasonality of influenza epidemics. Proc Natl Acad Sci U S A 101: 16915–16916.
[27]
Longini IM, Ackerman E, Elveback LR (1978) Optimization model for influenza A epidemics. Math Biosci 38: 141–157.
[28]
Mills CE, Robins JM, Lipsitch M (2004) Transmissibility of 1918 pandemic influenza. Nature 432: 904–906.
[29]
Ferguson NM, Cummings DA, Cauchemez S, Fraser C, Riley S, et al. (2005) Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature 437: 209–214.
[30]
Emanuel EJ, Wertheimer A (2006) Public health—Who should get influenza vaccine when not all can? Science 312: 854–855.
[31]
Kavanagh E, editor. (2006) Letters: The ethics of influenza vaccination. Science 313: 758–760.
